MaBel GmbH
Records under this name other than patents MaBel GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to MaBel GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,610,292 | Uses for 4,17β-dihydroxyandrost-4-ene-3-one Formerly held Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |
| US 9,138,477 | Uses for 4,17β-dihydroxyandrost-4-ene-3-one Formerly held Lapsed on the fee record Ended Sep 22, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | USPTO record |
| US 9,114,163 | Medication against breast cancer and related diseases Formerly held Lapsed on the fee record Ended Aug 25, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2023 | USPTO record |